New FDA Approval Extends Label to Including the i:X's Detection of Bacteria and Digital Wound Measurement TORONTO, Dec. 5, 2019 /CNW/ - MolecuLight Inc., the world's leader in handheld fluorescence ...
MolecuLight today announced that the United States International Trade Commission ("ITC") has formally instituted an ...
PITTSBURGH, PA, May 4, 2021 /PRNewswire/ – MolecuLight Corp., the leader in point-of-care fluorescence imaging for detection of wounds containing elevated bacterial loads, announces its MolecuLight ...
Patient Wounds Documented by MolecuLight i:X Device Now Integrated with EHR Systems Through Net Health’s Tissue Analytics Platform For clinical sites using both MolecuLight and Tissue Analytics, wound ...
PITTSBURGH, July 10, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr. Julia Wright, MD, FACP, as its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results